Updates in Hypertension Studies According to the Main Clinical Trials: A Review of the Past 45 Years about Pharmaceutical Intervention Effects
Background: High blood pressure remains one of the most important risk factors for cardiovascular disease. Although there is no consensus, all the clinical practice guidelines agree on the need to reduce blood pressure levels to minimize the risks. There are many clinical trials conducted to try to...
Main Author: | Jose Manuel Martínez-Linares |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Nursing Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2039-4403/10/1/2 |
Similar Items
-
CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2
by: V. V. Popov, et al.
Published: (2015-12-01) -
CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1
by: V. V. Popov, et al.
Published: (2015-12-01) -
Non-pharmacological interventions in hypertension: A community-based cross-over randomized controlled trial
by: Hema Subramanian, et al.
Published: (2011-01-01) -
Interventional and Surgical Treatments for Pulmonary Arterial Hypertension
by: Tomasz Stącel, et al.
Published: (2021-07-01) -
Main results of the Russian trial «ALTAIR»
by: E. V. Shlyakhto, et al.
Published: (2006-02-01)